Skip to main content


U. Mich. Explores Drug Printing Technology

By John Commins  
   October 04, 2017

That’s worth a lot. You reduce the inconvenience, you increase the precision with which it is done, and in a smaller area you can test a lot more allergens. You have to release these things in very small quantities because otherwise you can trigger a bad reaction. Well, this technique allows you to put a lot of different compounds into a small area and release small amounts. It’s compact and you can easily ship them. There is that potential.  

HLM: What’s next?

Shtein: Our main thing is developing technologies that are ultimately going to help people. We are not just playing in the sandbox in isolation, so the faster we can do it the better.

John Commins is a content specialist and online news editor for HealthLeaders, a Simplify Compliance brand.

Get the latest on healthcare leadership in your inbox.